📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mg | 360 pills | £0.78 | £402.22 £281.55 Best Price | |
| 100mg | 270 pills | £0.80 | £309.85 £216.90 | |
| 100mg | 180 pills | £0.84 | £217.49 £152.24 | |
| 100mg | 120 pills | £0.92 | £157.90 £110.53 | |
| 100mg | 90 pills | £1.00 | £128.10 £89.67 | |
| 100mg | 60 pills | £1.13 | £96.82 £67.77 | |
| 100mg | 30 pills | £1.56 | £67.02 £46.92 | |
| 200mg | 360 pills | £0.83 | £429.03 £300.32 Popular | |
| 200mg | 270 pills | £0.87 | £333.69 £233.58 | |
| 200mg | 180 pills | £0.92 | £235.37 £164.76 | |
| 200mg | 120 pills | £0.99 | £169.82 £118.87 | |
| 200mg | 90 pills | £1.06 | £137.04 £95.93 | |
| 200mg | 60 pills | £1.22 | £104.27 £72.99 | |
| 200mg | 30 pills | £1.67 | £71.49 £50.05 |
Excessive daytime sleepiness is a key feature of several sleep and wakefulness disorders, and maintaining alertness during the day can support safety and daily functioning. Modafinil is a wakefulness‑promoting medication that is used to reduce this daytime sleepiness in certain conditions. The active ingredient is modafinil, presented in the UK brand Provigil.
Provigil belongs to a class of medicines sometimes described as eugeroics (agents that promote wakefulness) rather than traditional stimulants. The precise mechanism is not fully understood, but it is believed to influence several brain systems involved in wakefulness with a distinct profile from stimulants such as amphetamines.
Provigil is prescribed to improve daytime alertness and reduce sleepiness in people with narcolepsy, obstructive sleep apnoea/hypopnoea syndrome when daytime sleepiness persists despite treatment of the breathing disorder, and shift work sleep disorder. It is intended to help maintain wakefulness during the day and to support daytime functioning.
In practice, Provigil should be used only under medical supervision, with a plan that considers the underlying condition, concomitant therapies, and any potential safety concerns. If the official leaflet or a healthcare professional raises questions about suitability, those sources should be consulted for personalised advice.
Narcolepsy is a neurological disorder characterised by sudden and unpredictable episodes of sleepiness during the day, often accompanied by brief attacks of muscle weakness or “cataplexy.” In narcolepsy, Provigil may help to reduce daytime sleep attacks and to improve the ability to stay awake in daily activities and at work or school.
Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) involves repeated pauses in breathing during sleep, which can lead to poor sleep quality and daytime sleepiness. When the breathing disorder is being managed but daytime sleepiness persists, Provigil may be considered to support daytime wakefulness and function.
Shift work sleep disorder occurs when working rotating or night shifts disrupts normal sleep patterns, resulting in excessive sleepiness or fatigue at work. Provigil can be used to enhance alertness during work periods and to improve performance and safety in appropriate cases.
Other conditions with chronic daytime sleepiness may be considered by some clinicians when standard treatments have not achieved adequate relief. In each case, the decision to use Provigil depends on a careful assessment of benefits and risks, and ongoing monitoring by a healthcare professional is advised.
The precise mechanism by which modafinil promotes wakefulness is not completely understood. It is thought to act on multiple brain pathways that regulate alertness, including brain regions involved in arousal and attention.
One aspect of its action appears to involve the brain’s orexin (also known as hypocretin) system, which plays a crucial role in maintaining wakefulness. Another aspect involves interactions with neurotransmitter systems that influence mood, motivation, and alertness, though these effects are distinct from those produced by standard stimulant drugs.
Because of its multifaceted action, Provigil may have a different side‑effect profile and risk of dependence compared with traditional stimulants. The medication is generally prescribed with careful consideration of potential cardiovascular or psychiatric effects, and with monitoring plans in place.
In all cases, the exact mechanism should be considered as part of a broader clinical picture rather than as a sole explanation for the effects observed. If questions arise about how Provigil may interact with existing medical conditions, a healthcare professional should be consulted for clarification.
Provigil is taken by mouth as a tablet and should be used exactly as prescribed by a clinician. The timing is generally planned to support daytime wakefulness while minimising sleep disturbances at night.
Typically, tablets are taken once daily in the morning or about one hour before the start of a planned period of wakefulness, such as the beginning of a work shift. The exact timing and duration of treatment are tailored to the individual and may change over time based on response and tolerability.
The tablets may be taken with or without food. The presence of fat in a meal can sometimes affect the rate of absorption, potentially altering how quickly effects are felt. It is important to follow the prescribing clinician’s instructions and to avoid altering the dosing regimen without professional advice.
If a dose is missed or if the schedule is disrupted, guidance should be sought from a pharmacist or doctor. Do not double up doses to compensate for a missed dose unless instructed by a clinician, and seek urgent medical help if there is any concern about a potential overdose or severe reaction.
Provigil should not be used by individuals with a known hypersensitivity to modafinil or any of the other ingredients in the tablet. A history of severe allergic reactions to similar medicines requires careful consideration and professional guidance before use.
Concomitant conditions that may increase risk or reduce benefit require careful assessment. Caution is advised in people with significant liver problems, certain cardiovascular conditions, or mental health disorders, as well as in those with a history of severe skin reactions.
Provigil is not a suitable option for everyone, and it may not be recommended during pregnancy or while breastfeeding unless a clinician determines that the potential benefits outweigh possible risks. A full review of medical history, current medicines, and lifestyle factors is essential before starting treatment.
In all cases, the decision to use Provigil should be made in collaboration with a healthcare professional who can assess individual risk factors and provide guidance based on the official information leaflets and local guidelines.
Potential adverse effects may occur, including allergic reactions, skin rashes, or more serious, rare events. Any signs of a severe skin reaction—such as widespread rash, blistering, or peeling skin—should prompt immediate medical evaluation. If such symptoms appear, seek urgent medical help.
Neuropsychiatric symptoms can arise, including anxiety, agitation, irritability, mood changes, or insomnia. If new or worsening psychiatric symptoms occur, a clinician should be consulted promptly to evaluate the risk–benefit balance of continuing treatment.
Cardiovascular effects, such as increased heart rate or blood pressure, may occur especially in people with underlying heart conditions or uncontrolled hypertension. Regular monitoring may be advised, and any concerning symptoms such as chest pain or fainting should be discussed with a healthcare professional.
Provigil may interact with other medicines, supplements, or certain foods. A full medication history should be reviewed before starting treatment, and any changes to other therapies should be discussed with a pharmacist or clinician to avoid adverse interactions.
Headache, nausea, dry mouth, and dizziness are commonly reported in some patients. These effects are usually mild to moderate and may lessen with continued use or after dose adjustments under medical supervision.
Some individuals may experience difficulty sleeping, anxiety, or stomach upset. If sleep disturbances are troublesome or persistent, the timing of dosing may need to be reviewed with a clinician to optimise daytime wakefulness while preserving night-time rest.
Rarer reactions can include skin rashes or mood changes. If a skin rash or any signs of an allergic reaction occur, such as swelling of the face or lips, seek medical advice promptly. Persistent or severe adverse effects should be reported to a healthcare professional.
Longer‑term use requires ongoing assessment of safety and effectiveness. If symptoms persist or new concerns arise after several weeks or months of therapy, a healthcare professional should be consulted to determine the appropriate course of action.
Modafinil may influence how other medicines work and vice versa. The potential for drug interactions exists with medicines that are processed by similar liver enzymes or that affect central nervous system function. A comprehensive medication list should be reviewed with a pharmacist or clinician before starting Provigil.
Certain hormonal contraceptives and other hormone‑based therapies can be affected by enzyme‑modifying drugs, potentially reducing effectiveness. If contraception is a consideration, a clinician may discuss alternatives or additional precautions as appropriate.
Caffeine and alcohol can influence wakefulness and mood, with alcohol potentially increasing sedation or impairment in some contexts. It is advisable to discuss caffeine intake and alcohol use with a healthcare professional when Provigil therapy is planned or underway.
Herbal supplements or over‑the‑counter formulations may interact with Provigil. It is important to disclose all non-prescription products to a clinician to prevent unexpected interactions. For any new medicine, a pharmacist should be consulted before starting Provigil.
Data regarding the safety of Provigil in pregnancy are limited. If pregnancy is planned or suspected, a clinician should be consulted to discuss potential risks and alternatives. The decision should be based on an assessment of benefits and potential risks to the fetus.
Breastfeeding while taking Provigil is generally not recommended because the active substance may pass into breast milk. A clinician can provide guidance on whether to discontinue the medication or to choose a different treatment approach during the breastfeeding period.
In all cases, the risks and benefits should be carefully weighed, and decisions should be made in collaboration with a healthcare professional. If pregnancy occurs during treatment, contact a clinician promptly for advice on safe management.
For individuals planning to start a family, or those who are already pregnant or breastfeeding, check the official leaflets and seek professional advice to ensure safety and appropriate alternatives are considered.
Some people notice improved wakefulness within hours of the first dose, while others may require several days of regular dosing to achieve the full effect. Individual response can vary based on the underlying sleep disorder and concurrent medications. If there is no noticeable improvement after a couple of weeks, a clinician should be consulted to review treatment.
If a dose is missed, it should not be double‑dosed to compensate. Guidance from a pharmacist or clinician should be followed, which may involve taking the next dose at the usual time or skipping the missed dose if it is near the time for the next scheduled dose. Do not alter dosing without professional input.
Caffeine may amplify stimulant‑like effects and can contribute to sleep disturbance in some individuals. Alcohol can worsen daytime sleepiness or interact with mood and alertness in unpredictable ways. It is reasonable to moderate or avoid these substances while undergoing Provigil therapy, with guidance from a clinician.
Provigil may be used for extended periods if a clinician judges it to be beneficial and safe. Regular reviews are recommended to assess continuing need, effectiveness, and any adverse effects. Treatment duration should be guided by clinical response and ongoing risk assessment.
Any persistent or troublesome side effects should be discussed with a healthcare professional. Some effects may lessen over time, while others may require dose adjustments or a change in therapy. Immediate medical attention is necessary for severe reactions or signs of an allergic response.
Wakefulness promotion can improve alertness, but individual responses vary. If daytime sleepiness or dizziness occurs, driving or operating heavy machinery should be approached with caution until stability is confirmed by a clinician. Abrupt changes in wakefulness may also affect performance.
Pregnancy and breastfeeding considerations require professional input. It is important to discuss potential risks and alternatives with a clinician, who will consider the specific clinical context and the available official guidance in the United Kingdom.
Drug interactions may occur with certain medications, particularly those processed by liver enzymes or those that affect the central nervous system. A full medication review should be conducted before starting Provigil, and any new medicines should be discussed with a pharmacist or clinician.
Provigil may require a prescription depending on local rules and clinical considerations. Availability can vary by country and healthcare setting. The decision about prescription status is determined by national regulations and the prescribing clinician.
Regular follow‑up with a clinician is typically advised to monitor response, adverse effects, and overall safety. Blood pressure, heart rate, mood changes, and sleep quality may be reviewed as part of ongoing assessment. Any new symptoms should be reported promptly.
The official patient information leaflet supplied with Provigil contains detailed prescribing information, warnings, and instructions. It should be read carefully and kept for reference during treatment. If any section is unclear, a pharmacist or clinician can explain it in plain terms.
Healthcare professionals, including general practitioners and sleep specialists, can provide personalised advice and answer questions about suitability, dosing, and monitoring. Pharmacists can also review the medication list for potential interactions and provide guidance on safe use in daily life.
In the United Kingdom, regulatory agencies and professional guidelines offer additional information about the safe and effective use of wakefulness‑promoting medicines. If concerns persist after consulting the official leaflet and a clinician, seek a second opinion or contact a local pharmacy for an impartial review of options.
Always report any adverse reactions or unexpected effects to a clinician or pharmacist. This helps to ensure safe treatment continuity and contributes to broader knowledge about the real‑world safety profile of Provigil. Official resources should be consulted for the most current guidance.
14–21 days. Free from £150.26 .
5–9 days. £22.54
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
